Neurologic clinical trial - Silver Creek Pharmaceuticals, Inc.

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05585606

A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke

Drug

Scp776

Phase

Phase II

Condition

Acute Ischemic Stroke